journal
https://read.qxmd.com/read/39235357/large-scale-evidence-for-the-validity-of-remote-moca-administration-among-people-with-cerebellar-ataxia
#1
JOURNAL ARTICLE
Yael De Picciotto, Avigail Lithwick Algon, Inbal Amit, Eli Vakil, William Saban
Objective : For over half a century, studies of rare diseases using in-person cognitive tools have faced challenges, such as long study periods and small sample sizes (e.g. n  = 10). The Montreal Cognitive Assessment (MoCA) was widely employed to assess mild cognitive impairment (MCI). We aimed to validate a modified online version of the MoCA in a large sample of a rare disease (population prevalence < .01%). Method : First, we analyzed 20 previous findings ( n  = 1,377), comparing the MoCA scores between large groups of neurotypically healthy (NH; n  = 837) and cerebellar ataxia (CA; n  = 540), where studies were conducted in-person...
September 5, 2024: Clinical Neuropsychologist
https://read.qxmd.com/read/39233356/a-clinical-evaluation-program-to-monitor-neurocognitive-risk-in-children-and-adolescents-with-sickle-cell-disease
#2
JOURNAL ARTICLE
Jennifer N Longoria, Jane E Schreiber, Brian Potter, Darcy Raches, Erin MacArthur, Diana Cohen, Marshetta Brazley-Rodgers, Jane S Hankins, Andrew M Heitzer
Objective: Sickle cell disease (SCD) is an inherited hematologic disorder that impacts approximately 100,000 Americans. This disease is associated with progressive organ damage, cerebral vascular accident, and neurocognitive deficits. Recent guidelines from the American Society of Hematology (ASH) recommend cognitive screening with a psychologist to help manage cerebrovascular risk and cognitive impairment in this population. SCD patients benefit from neuropsychology services and several institutions already have programs in place to monitor cognitive risk...
September 4, 2024: Clinical Neuropsychologist
https://read.qxmd.com/read/39225135/correction
#3
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
September 3, 2024: Clinical Neuropsychologist
https://read.qxmd.com/read/39180168/the-role-of-cognitive-reserve-and-depression-on-executive-function-in-older-adults-a-10-year-study-from-the-wisconsin-registry-for-alzheimer-s-prevention
#4
JOURNAL ARTICLE
Loredana Frau, Erin Jonaitis, Rebecca E Langhough, Megan Zuelsdorff, Ozioma Okonkwo, Davide Bruno
Objective: The current study examined the longitudinal relationship between cognitive reserve (CR), depression, and executive function (EF) in a cohort of older adults. Methods : 416 participants were selected from the Wisconsin Registry for Alzheimer's Prevention. They were native English speakers, aged ≥50+, and cognitively unimpaired at baseline, with no history of neurological or other psychiatric disorders aside from depression. Depression was assessed with the 20-item Center for Epidemiologic Studies Depression Scale (CES-D)...
August 23, 2024: Clinical Neuropsychologist
https://read.qxmd.com/read/39177216/neuropsychology-practice-guidance-for-the-neuropsychiatric-aspects-of-long-covid
#5
REVIEW
Christine H Koterba, Ciaran M Considine, Jacqueline H Becker, Kristen R Hoskinson, Rowena Ng, Gray Vargas, Michael R Basso, Antonio Enrique Puente, Sara M Lippa, Douglas M Whiteside
Objective: The coronavirus disease-2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has had a profound global impact on individual health and well-being in adults and children. While most fully recover from COVID-19, a relatively large subgroup continues to experience persistent physical, cognitive, and emotional/behavioral symptoms beyond the initial infection period. The World Health Organization has termed this phenomenon "Post-COVID-19 Condition" (PCC), better known as "Long COVID...
August 23, 2024: Clinical Neuropsychologist
https://read.qxmd.com/read/39158158/health-insurance-coverage-moderates-the-relationship-between-metabolic-syndrome-and-baseline-memory-outcomes-in-latino-older-adults
#6
REVIEW
Jordana Breton, Janelle T Foret, Abbey M Hamlin, Nazareth Ortega, Alexandra L Clark
Objective: Latino adults are at increased risk of metabolic syndrome (MetS) and have lower rates of health insurance (HI) coverage. Although inadequate HI coverage and MetS have been independently linked to poor cognition, their potential interactive effects have not yet been examined. The present study explored whether HI moderated the association between MetS and cognition. We hypothesized that Latinos with MetS that did not have HI would demonstrate poorer cognition than those with HI, whereas there would be minimal differences in cognition across HI status in those without MetS...
August 19, 2024: Clinical Neuropsychologist
https://read.qxmd.com/read/39154259/hashimoto-encephalopathy-a-literature-review-and-case-report-with-comprehensive-neuropsychological-evaluation
#7
JOURNAL ARTICLE
Lauren A-M Schenck, Halle T McCracken, Frank Andrasik, Brandon C Baughman
Objective: Hashimoto's encephalopathy (HE), a rare immune-mediated disorder, manifests as altered mental state, cognitive and psychological dysfunction, seizures, and myoclonus. Little is known, however, about the neuropsychological profiles of individuals with HE due to the sparse amount of research. This report overviews HE, summarizes findings from available published neuropsychological evaluations, and details neuropsychological examinations of a 57-year-old White woman with a confirmed HE diagnosis evidencing persistent neuropsychological impairment at two discrete timepoints...
August 18, 2024: Clinical Neuropsychologist
https://read.qxmd.com/read/39138860/performance-validity-in-a-presurgical-epilepsy-population
#8
JOURNAL ARTICLE
Sofia Lesica, Hien Luu, Michael Lawrence
Objective: This study examined the performance validity test (PVT) pass/fail rate in a sample of presurgical epilepsy candidates; assessed whether performance validity was associated with reduced performance across cognitive domains; investigated the relationship between performance validity and self-report mood questionnaires; and assessed whether PVT performance was associated with demographic or clinical factors (i.e. sex, race/ethnicity, age, years of education, reported history of special education, seizure longevity, and number of anti-seizure medications)...
August 13, 2024: Clinical Neuropsychologist
https://read.qxmd.com/read/39135427/methods-for-assessment-of-rey-auditory-verbal-learning-test-performance-in-memory-clinic-patients-and-healthy-adults-at-the-cross-roads-of-learning-theory-and-clinical-utility
#9
JOURNAL ARTICLE
Ove Almkvist, Anna Rennie, Eric Westman, John Wallert, Urban Ekman
Background: Knowledge is still lacking regarding the preferred method for evaluation of learning in the Rey Auditory Verbal Learning Test (RAVLT). Validity of different methods was examined by the effect size in differentiating diagnostic stages in memory clinic patients versus healthy adults and the strength of association between RAVLT performance and brain atrophy. Method: The study included individuals with dementia ( n  = 247), Mild Cognitive Impairment (MCI, n  = 709), Subjective Cognitive Impairment (SCI, n  = 175) and cognitively unimpaired adults serving as healthy controls (HC, n  = 102)...
August 12, 2024: Clinical Neuropsychologist
https://read.qxmd.com/read/39135404/neuropsychological-and-behavioural-outcomes-in-epilepsy-involving-the-insula-a-scoping-review
#10
REVIEW
Tamara P Tavares, Julia M Young, Vanessa V Chen, Elizabeth N Kerr, Eva Mamak, Quenby Mahood, Mary Lou Smith
Objective: In patients with epilepsy, the insula has been increasingly recognized as a common site of seizures. There is growing interest in understanding the cognitive and psychological consequences of insular epilepsy to help provide clinical recommendations to support patient's cognitive and psychosocial functioning, and to help identify candidates for epilepsy resective surgery. The aim of this scoping review was to describe the cognitive and behavioural characteristics associated with insular epilepsy in children and adults...
August 12, 2024: Clinical Neuropsychologist
https://read.qxmd.com/read/39096060/cultural-and-multicultural-topics-in-neuropsychology-journal-titles-from-2010-2020
#11
JOURNAL ARTICLE
Rebecca E Ready, Eleni Kapoulea, Irina Orlovsky, Maya Whaley, Hanan S Rafiuddin
OBJECTIVE: The values of a field are reflected in the science it publishes. The goal of this study was to present a historical analysis of the extent to which the field of clinical neuropsychology publishes journals with titles that address culture in the context of brain function and behavior between 2010 and 2020. METHODS: Titles from articles published in 13 neuropsychology journals from 2010-2020 were collected and coded with regard to culture and multicultural content...
August 3, 2024: Clinical Neuropsychologist
https://read.qxmd.com/read/39086212/prevalence-of-neurocognitive-impairment-in-patients-with-rheumatoid-arthritis-a-systematic-review-and-meta-analysis
#12
REVIEW
Daniel Pankowski, Kinga Wytrychiewicz-Pankowska, Ewa Pisula, Andrzej M Fal
Objective This study aimed to evaluate prevalence rates (PRs) of neurocognitive impairment and its potential moderators among patients with rheumatoid arthritis (RA). Method A systematic review of the available literature and data extraction was undertaken on 6 August 2021, with the update by 14 September 2023, by two reviewers independently. Literature was screened for reported rates of prevalence of neurocognitive impairment in RA patients. The meta-analysis was performed using RStudio with the "meta" library...
July 31, 2024: Clinical Neuropsychologist
https://read.qxmd.com/read/39060986/the-mobile-everyday-cognition-scale-mecog-development-and-pilot-testing
#13
JOURNAL ARTICLE
Sawyer Harmon, Courtney G Kocum, Rylea M Ranum, Greta Hermann, Sarah Tomaszewski Farias, Andrew M Kiselica
Objective: Subjective cognitive decline (SCD) is an important part of the aging process and may be a sign of neurodegenerative disease. Current measures of SCD are subject to the limits of retrospective recall of symptoms over a long span of time, which might be addressed by using ecological momentary assessment (EMA) methods. However, there are no currently available measures of SCD validated for use in EMA. Thus, our goal was to develop and pilot test the mobile Everyday Cognition Scale (mECog). Method: 31 community-dwelling older adults completed in lab measures of cognition and mental health symptoms, followed by daily mECog ratings on a smart phone for 28 days...
July 26, 2024: Clinical Neuropsychologist
https://read.qxmd.com/read/39060956/neuropsychological-profile-associated-with-financial-exploitation-vulnerability-in-older-adults-without-dementia
#14
JOURNAL ARTICLE
Aaron C Lim, Gali H Weissberger, Jenna Axelrod, Laura Mosqueda, Annie L Nguyen, Laura Fenton, Daisy Noriega, Camille E Erdman, S Duke Han
Objective: Reports of financial exploitation have steadily increased among older adults. Few studies have examined neuropsychological profiles for individuals vulnerable to financial exploitation, and existing studies have focused on susceptibility to scams, one specific type of financial exploitation. The current study therefore examines whether a general measure of financial exploitation vulnerability is associated with neuropsychological performance in a community sample. Methods : A sample ( n  = 116) of adults aged 50 or older without dementia completed a laboratory visit that measures physical and psychological functioning and a neuropsychological assessment, the Uniform Data Set-3 (UDS-3) and California Verbal Learning Test-II...
July 26, 2024: Clinical Neuropsychologist
https://read.qxmd.com/read/39056491/providing-a-brief-corrective-statement-does-not-improve-test-performance-in-patients-invalidating-testing-a-multisite-single-blind-randomized-controlled-trial
#15
JOURNAL ARTICLE
Jeroen J Roor, Brechje Dandachi-FitzGerald, Maarten J V Peters, Rudolf W H M Ponds
Objective: Performance below the actual abilities of the examinee can be measured using performance validity tests (PVTs). PVT failure negatively impacts the quality of the neuropsychological assessment. In our study, we addressed this issue by providing a brief corrective statement regarding invalidity to improve test-taking behavior. Methods: This study is a multisite single-blind randomized controlled trial in a consecutive sample of clinically referred adult patients ( N  = 196) in a general hospital setting...
July 26, 2024: Clinical Neuropsychologist
https://read.qxmd.com/read/39044371/culturally-informed-neuropsychological-evaluations-of-patients-with-spina-bifida-application-of-the-eclectic-framework-to-a-complex-pediatric-medical-condition
#16
JOURNAL ARTICLE
Rosalia Costello, Beatriz MacDonald, Jaclyn L Papadakis, Lizabeth L Jordan
Objective: The pediatric patient populations in the United States are becoming increasingly diverse in culture. In addition to medical factors, a variety of sociocultural factors (including educational systems, language, immigration status, etc.) can impact a child's cognitive development, performance on traditional neuropsychological measures, provider interactions, differential diagnosis, and recommendations. A culturally-informed neuropsychological evaluation aims to understand the impact of sociocultural factors and integrate them into the assessment approach...
July 23, 2024: Clinical Neuropsychologist
https://read.qxmd.com/read/39034486/does-generative-artificial-intelligence-pose-a-risk-to-performance-validity-test-security
#17
JOURNAL ARTICLE
Shannon Lavigne, Anthony Rios, Jeremy J Davis
OBJECTIVE: We examined the performance validity test (PVT) security risk presented by artificial intelligence (AI) chatbots asking questions about neuropsychological evaluation and PVTs on two popular generative AI sites. METHOD: In 2023 and 2024, multiple questions were posed to ChatGPT-3 and Bard (now Gemini). One set started generally and refined follow-up questions based on AI responses. A second set asked how to feign, fake, or cheat. Responses were aggregated and independently rated for inaccuracy and threat...
July 21, 2024: Clinical Neuropsychologist
https://read.qxmd.com/read/39016843/neuropsychological-functioning-after-covid-19-minor-differences-between-individuals-with-and-without-persistent-complaints-after-sars-cov-2-infection
#18
JOURNAL ARTICLE
Anouk Verveen, Sander C J Verfaillie, Denise Visser, Dook W Koch, Esmée Verwijk, Gert J Geurtsen, Jeroen Roor, Brent Appelman, Ronald Boellaard, Caroline M van Heugten, Janneke Horn, Hanneke E Hulst, Menno D de Jong, Tanja A Kuut, Tessa van der Maaden, Yvonne M G van Os, Maria Prins, Johanna M A Visser-Meily, Michele van Vugt, Cees C van den Wijngaard, Pythia T Nieuwkerk, Bart van Berckel, Nelleke Tolboom, Hans Knoop
Objective: It is unclear how self-reported severe fatigue and difficulty concentrating after SARS-CoV-2 infection relate to objective neuropsychological functioning. The study aimed to compare neuropsychological functioning between individuals with and without these persistent subjective complaints. Method : Individuals with and without persistent severe fatigue (Checklist Individual Strength (CIS) fatigue ≥ 35) and difficulty concentrating (CIS concentration ≥ 18) at least 3 months after SARS-CoV-2 infection were included...
July 17, 2024: Clinical Neuropsychologist
https://read.qxmd.com/read/38997666/tics-m-scores-in-an-oldest-old-normative-cohort-identified-by-computable-phenotype
#19
JOURNAL ARTICLE
Gelan Ying, Ambar Perez-Lao, Tamare Adrien, Demetrius Maraganore, David Marra, Glenn Smith
Objective: To (1) examine the distribution of Telephone Interview for Cognitive Status modified (TICS-m) scores in oldest-old individuals (age 85 and above) identified as cognitively healthy by a previously validated electronic health records-based computable phenotype (CP) and (2) to compare different cutoff scores for cognitive impairment in this population. Method: CP identified 24,024 persons, 470 were contacted and 252 consented and completed the assessment. Associations of TICS-m score with age, sex, and educational categories (<10 years, 11-15 years, and >16 years) were examined...
July 12, 2024: Clinical Neuropsychologist
https://read.qxmd.com/read/38993089/influence-of-social-determinants-of-health-and-adversity-on-computerized-neurocognitive-assessment
#20
JOURNAL ARTICLE
Jillian Lemke, Alena Sorensen D'Alessio, Farren B S Briggs, Christopher Bailey
Introduction: Social determinants of health and adversity, including poverty, maltreatment, and neighborhood deprivation, are individual-level factors that may significantly affect baseline neurocognitive testing and management that have yet to be thoroughly explored within the computerized neurocognitive assessment. Objectives: Examine individual-level experiences of poverty, abuse, neighborhood deprivation, and social mobility on computerized cognitive testing. Methods: The sample included 3,845 student-athletes who completed a baseline Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) and were enrolled in the Child-Household Integrated Longitudinal Data database...
July 12, 2024: Clinical Neuropsychologist
journal
journal
29848
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.